UZ/KU Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
Location contact
Laura van Gerven
PRINCIPAL_INVESTIGATOR
Marnick Clijsters
CONTACT
Marnick Clijsters
SUB_INVESTIGATOR
NCT Number: NCT06456008
Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related smell disorders.
With this observational ambidirectional study, the investigators aim to better map smell/taste disorders in the Belgian/Flemish population. Using standard-of-care diagnostic tests and structured questionnaires, the investigators strive to gain more insight into the severity, impact, and progression/prognosis of smell/taste disorders.
Interested in participating?
Request InfoAll sexes
Observational
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
Laura van Gerven
PRINCIPAL_INVESTIGATOR
Marnick Clijsters
CONTACT
Marnick Clijsters
SUB_INVESTIGATOR
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
There are no exclusion criteria related to sex, gender, or ethnicity. There are no exclusion criteria related to medical history or prior treatments.
Standard of care
Time frame: Observational up to 5 years follow-up
Contact information is provided by the study sponsor or research team.
Universitaire Ziekenhuizen KU Leuven
Other
Prospective Registry of Outcome and Correlates of Chemosensory Dysfunction at the Smell & Taste Clinic of UZ Leuven
Acronym: ProspeRo'Scent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05855369
Anosmia, COVID-19
Charleston, South Carolina, United States
View Trial DetailsNCT06115291
Brain Concussion, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT04466982
Anosmia, COVID-19
Cambridge, United Kingdom
View Trial DetailsNCT03990766
Anosmia, Infections
St Louis, Missouri, United States
View Trial Details